Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Hair growth phase in mice weakens certain immune responses.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Skin inflammation can worsen intestinal inflammation and colitis.

ILC1-like cells may contribute to hair loss in alopecia areata.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Moderate immune responses help hair growth, while excessive responses slow it down.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Inflammation helps stem cells repair tissue by directing their behavior.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Homeopathy might help manage autoimmune diseases.